Records containing: Multiple Endocrine Neoplasia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-28Coordination of Rare Diseases at Sanford
-
CLINICAL_TRIALS study record update · 2026-01-14Institutional Registries of Rare Diseases at Hospital Italiano de Buenos Aires (HIBA)
-
CLINICAL_TRIALS study record update · 2025-05-29Coordination of Rare Diseases at Sanford
-
CLINICAL_TRIALS study record update · 2024-12-18The Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT)
-
CLINICAL_TRIALS study record update · 2023-04-13A Retrospective Study for Multiple Endocrine Neoplasia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-01-20Family Studies in Metabolic Diseases and Mineral Metabolism
-
CLINICAL_TRIALS study record update · 2022-06-07Studies of Hyperparathyroidism and Related Disorders
-
CLINICAL_TRIALS study record update · 2020-11-18Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes
-
CLINICAL_TRIALS study record update · 2019-09-12Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)
-
CLINICAL_TRIALS study record update · 2019-05-23Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1 Patients
-
CLINICAL_TRIALS study record update · 2017-11-21Study and Follow-up of Multiple Endocrine Neoplasia Type 1
-
CLINICAL_TRIALS study record update · 2017-03-03A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2012-10-19Long-Term Study of the Efficacy and Safety of Lansoprazole in the Treatment of Zollinger-Ellison and Other Acid Hypersecretors
-
CLINICAL_TRIALS study record update · 2009-10-07Efficacy and Safety of High Dose Regimen of Octreotide LAR in Patients With Neuroendocrine Tumors in Progressive Disease: A Phase II, Open, Multicentric Prospective Study